MUC2 and pancreatic intraductal papillary-mucinous neoplasm: Intestinal-type IPMN accounts for about 20–30% of cases, 50% of them present with high-grade dysplasia, and immunostaining reveals MUC2 and CDX2 expression (MUC2 positive, CDX2 positive).